Daniel J. Becker's Net Worth
-$11.7 Thousand
Who is Daniel J. Becker?
Daniel J. Becker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Day One Biopharmaceuticals, Inc., Pandion Therapeutics Holdco LLC, Principia Biopharma Inc., and ACELYRIN, Inc..
SEC CIK
Daniel J. Becker's CIK is 0001752139
Past Insider Trading and Trends
2023 was Daniel J. Becker's most active year for acquiring shares with 4 total transactions. Daniel J. Becker's most active month to acquire stocks was the month of May. 2020 was Daniel J. Becker's most active year for disposing of shares, totalling 3 transactions. Daniel J. Becker's most active month to dispose stocks was the month of August. 2021 saw Daniel J. Becker paying a total of $80,000.00 for 68,000 shares, this is the most they've acquired in one year. In 2021 Daniel J. Becker cashed out on 14,997 shares for a total of $60,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Day One Biopharmaceuticals, Inc. (DAWN) Snapshot price: $13.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
∞
| 5K |
$16.00 | $80,000.00 | 5K |
May 26 - Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Pandion Therapeutics Holdco LLC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.83M |
$60.00 | -$169,732,980.00 |
0
|
Apr 1
| |||
Form 4
| +7.52% | 197.72K |
$15.12 | $2,989,465.92 | 2.83M |
Nov 19
| |||
Form 4
| +1.13% | 29.39K |
$15.29 | $449,399.93 | 2.63M |
Nov 17 - Nov 18
| |||
Form 4
|
∞
| 2.6M |
$18.00 | $18,000.00 | 2.6M |
Jul 17 - Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Principia Biopharma Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -667.60K |
$100.00 | -$66,760,000.00 |
0
|
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
| +8.98% | 55K |
$29.94 | $1,646,700.00 | 667.6K |
Nov 20
| |||
Form 4
| +14.50% | 77.6K |
$33.48 | $2,598,025.97 | 612.6K |
Oct 28 - Oct 29
| |||
Form 4
|
∞
| 535K |
$28.00 | $14,980,000.00 | 535K |
Oct 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 13
| |||
Form 4
|
∞
| 2.63M |
$17.00 |
—
| 2.63M |
Sep 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ACELYRIN, Inc. (SLRN) Snapshot price: $4.25
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -0.03% | -1.00 |
$6.86 | -$6.86 | 3K |
Jul 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
∞
| 3K |
$18.00 | $54,000.00 | 3K |
May 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |